Therefore, it is not surprising that the ERK and AKT pathways are upregulated in osteosarcoma and involved in tumorigenic features such as apoptosis resistance, in vivo tumorigenicity and EMT [113,114]. This evidence concerns the gene AKT1 and osteosarcoma.